Essa Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Deals

15 July 2025

Trial results

16 April 2025

The company scraps nemvaleukin after the latest failure, of Artistry-6.

Trial results

1 November 2024

After beating "historical" Xtandi masofaniten fails to beat actual Xtandi.

Recent Quick take